Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Third Harmonic Bio, Inc. - Common Stock (NQ:THRD)

5.120 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Third Harmonic Bio, Inc. - Common Stock

< Previous 1 2 3 Next >
Top 3 Health Care Stocks You May Want To Dump This Quarter
Via Benzinga
Which stocks are moving on Monday?
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gapping stocks in Monday's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. 
Via Chartmill
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?
Third Harmonic Bio Inc (NASDAQ:THRD) shares are soaring on Monday after the company announced a plan of liquidation and dissolution. 
Via Benzinga
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered
The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual... 
Via Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape
Third Harmonic Bio plans a Phase 2 trial for THB335 in chronic spontaneous urticaria and will reduce its workforce by 50% while reviewing strategic options. 
Via Benzinga
Tuesday's session: top gainers and losers
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Tuesday's session: gap up and gap down stocks
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Which stocks are moving before the opening bell on Tuesday?
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
From Third Harmonic Bio
Via GlobeNewswire
Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Ingles Markets, Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in Upcoming Investor Conferences
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q2 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
From Third Harmonic Bio
Via GlobeNewswire
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q1 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
From Third Harmonic Bio
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS